We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Salt Depletion Enhances Drug Response

By Biotechdaily staff writers
Posted on 13 Jun 2002
Rats treated with diuretics to deplete their salt content became sensitized to amphetamine and developed an unusual pattern of neuronal growth in the part of the brain critical to motivation and reward. More...
These findings were published in the May 23, 2002, online issue of the Journal of Neuroscience.

In the study, researchers from the University of Washington (UW, Seattle, USA) first gave diuretics to a group of rats to deplete them of salt. Then they gave the animals a 3% saltwater solution, a mixture they ordinarily would not like or drink. This procedure was repeated two more times, with each treatment given a week apart. Brain tissues from these rats were then examined under a microscope, and these showed that nerve cells in the nucleus accumbens (the area of the forebrain that controls behavior related to motivation and reward) had more branches and were 30-35% longer than normal.

In another set of experiments, salt-depleted rats were tested for cross sensitization to amphetamine. The rats were allowed to explore an open, dark plastic enclosure with the floor divided into a grid by white tape. The salt-depleted rats and a control group of animals were then injected with amphetamine and placed in the enclosure. The psychostimulant effects of the drugs were measured by two behaviors--the number of taped lines each animal crossed over and how many times it reared up on its hind feet. The two groups did not differ in the number of lines each crossed, but the salt-depleted rats showed significantly more rearing behavior.

It is not yet known whether these results can be related directly to humans. However, Dr. Ilene Bernstein, a UW psychologist who led the research, says, "The same part of the brain and the response to drugs holds up across species. The same systems are involved in rats and humans when it comes to amphetamines and cocaine. This suggests evidence of a common natural substrate to natural and artificial rewards that is worth further investigation.”

She added that the findings also point to questions that need to be explored. These include determining how long cross sensitization persists and whether physical challenges such as salt depletion alter people's responses to drugs.




Related Links:
Univ. of Washington

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.